SCHEMBL22064055

SCHEMBL22064055

COc1ncc(-c2cccnc2)c2sc(NC(O)c3ccccc3)nc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
RAB9A P51151 3/20 0.39
GAA P10253 2/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALOX5 P09917 1/20 0.36
HPGD P15428 1/20 0.36
EPHB4 P54760 1/20 0.36
KCNA5 P22460 1/20 0.36
NPC1 O15118 2/20 0.35
ATM Q13315 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KDR P35968 1/20 0.35
GPR35 Q9HC97 1/20 0.35
POLB P06746 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
CHRM4 P08173 1/20 0.35
PDE10A Q9Y233 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24349657 0.84 ROCK2 (0.33) KDR
SCHEMBL22064054 0.79 CHRM4 (0.55) ALDH1A1RAB9ANPC1KDRPOLB
SCHEMBL20702380 0.76 EPHB4 (0.46) ALDH1A1RAB9AGAATSHRHSD17B10
SCHEMBL30127987 0.76 EPHB4 (0.46) ALDH1A1RAB9AGAATSHRHSD17B10
SCHEMBL20702379 0.73 CYP3A4 (0.48) RAB9AEPHB4NPC1ATMGPR35
SCHEMBL24713307 0.73 MAPT (0.37) ALDH1A1RAB9AALOX5HPGDNPC1
SCHEMBL22063313 0.73 ALDH1A1 (0.55) ALDH1A1RAB9ATSHRHSD17B10HPGD
SCHEMBL22064038 0.72 POLQ (0.36) ALDH1A1GAAALOX5KDRKDM4E
SCHEMBL20705299 0.71 CHRM4 (0.48) ALDH1A1RAB9APOLBCYP11B1CYP11B2
SCHEMBL30127887 0.71 CHRM4 (0.48) ALDH1A1RAB9APOLBCYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200181171-A1 THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS MERCK PATENT GMBH (DE) 2020-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181171-A1 THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS ADORA1, ADORA2A, AMPD2 ALDH1A1 585/4885RAB9A 3080/4885GAA 1264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.